---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-26-001447"
form_type: "8-K"
ticker: "ACBM"
cik: "0001622996"
company_name: "ACRO BIOMEDICAL CO., LTD."
filed_at: "2026-09-02T20:05:24+00:00"
generated_at: "2026-09-02T20:06:19.472131+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Acro Biomedical appoints new chairman and CEO; Su resigns

## Summary
- Yu-Ting Su resigned as director, chairman, and CEO on Sept 2, 2026, effective immediately.
- Board appointed Shao-Hsiang Shih as director and chairman, effective Sept 2, 2026.
- Jing-Zhou Chen appointed CEO and CFO, effective Sept 2, 2026.
- Su's resignation was not due to any disagreement with the company.

## SEC filing metadata
- accession: 0001640334-26-001447
- form_type: 8-K
- ticker: ACBM
- cik: 0001622996
- company_name: ACRO BIOMEDICAL CO., LTD.
- filed_at: 2026-09-02T20:05:24+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1622996/000164033426001447/0001640334-26-001447-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1622996/000164033426001447/acbm_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-26-001447
- JSON: https://secwatch.observer/filing/0001640334-26-001447.json
- Plain text: https://secwatch.observer/filing/0001640334-26-001447.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.